Original Research

Published on 07 Aug 2023

Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis

in Lipids in Cardiovascular Disease

Chen Lou
Zhizhen Meng
Yi-Yi Shi
Rui Zheng
Song-Zan Qian
Jingye Pan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1217922

5,993 views
7 citations

Review

Published on 07 Aug 2023

The therapeutic potential of sphingolipids for cardiovascular diseases

in Lipids in Cardiovascular Disease

Sapir Ya'ar Bar
Noam Pintel
Hesen Abd Alghne
Hamdan Khattib
Dorit Avni

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1224743

3,217 views
1 citation

Editorial

Published on 24 Jul 2023

Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets

in Lipids in Cardiovascular Disease

Simon Kraler
Tatsuya Sawamura
Grace Yen-Shin Harn
Chu-Huang Chen
Alexander Akhmedov

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1245716

1,107 views

Correction

Published on 21 Jul 2023

Corrigendum: The rationale for the treatment of long-COVID esymptoms—a cardiologist's view

in Lipids in Cardiovascular Disease

Frontiers Editorial Office

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1244340

1,248 views

Original Research

Published on 17 Jul 2023

The effect of non-optimal lipids on the progression of coronary artery calcification in statin-naïve young adults: results from KOICA registry

in Lipids in Cardiovascular Disease

Heesun Lee
Hyo-Jeong Ahn
Hyo Eun Park
Donghee Han
Hyuk-Jae Chang
Eun Ju Chun
Hae-Won Han
Jidong Sung
Hae Ok Jung
Su-Yeon Choi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1173289

1,800 views
1 citation

Systematic Review

Published on 27 Jun 2023

Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Guanwei Zhang
Jiajuan Guo
Hongguang Jin
Xiaojing Wei
Xing Zhu
Weitao Jia
Yongsheng Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1201107

2,285 views
5 citations

Review

Published on 26 Jun 2023

Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events

in Lipids in Cardiovascular Disease

Ruixing Zhang
Yongxiang Wang
Yu Peng
Jing Zhao
Zheng Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1117143

3,116 views

Case Report

Published on 23 Jun 2023

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report

in Lipids in Cardiovascular Disease

Massimiliano Allevi
Silvia Sarnari
Federico Giulietti
Francesco Spannella
Chiara Di Pentima
Riccardo Sarzani

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1181720

3,858 views
1 citation

Original Research

Published on 30 May 2023

Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients

in Lipids in Cardiovascular Disease

HariOm Singh
Chandrashekhar Jori
Shyamveer
Supriya D. Mahajan
Ravikumar Aalinkeel
Kathiravan Kaliyappan
Stanley A. Schwartz
Meenakshi Bhattacharya
Ruhi Shaikh
Madhukar Salve

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1177054

1,510 views
1 citation

Original Research

Published on 24 May 2023

Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages

in Lipids in Cardiovascular Disease

Martina B. Lorey
Amer Youssef
Lauri Äikäs
Matthew Borrelli
Martin Hermansson
Julia M. Assini
Aapeli Kemppainen
Hanna Ruhanen
Maija Ruuth
Sampsa Matikainen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1130162

3,600 views
2 citations

Original Research

Published on 23 May 2023

U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study

in Lipids in Cardiovascular Disease

Lihua Huang
Zhanpeng Lu
Xiaoyan You
Chunsheng Zou
Liuliu He
Jingxiang Xie
Xiaoqing Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1165338

2,646 views
4 citations

Original Research

Published on 18 May 2023

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study

in Lipids in Cardiovascular Disease

Xu-Min Guan
Hong-Po Shi
Shuang Xu
Yue Chen
Rong-Feng Zhang
Ying-Xue Dong
Lian-Jun Gao
Shou-Ling Wu
Yun-Long Xia

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1105342

1,597 views
5 citations

Correction

Published on 10 May 2023

Corrigendum: Loss of hepatic Surf4 depletes lipid droplets in the adrenal cortex but does not impair adrenal hormone production

in Lipids in Cardiovascular Disease

Xiaole Chang
Yongfang Zhao
Shucun Qin
Hao Wang
Bingxiang Wang
Lei Zhai
Boyan Liu
Hong-mei Gu
Da-wei Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1215335

720 views

Review

Published on 09 May 2023

Circulating sphingolipids in heart failure

in Lipids in Cardiovascular Disease

Anna Kovilakath
George Wohlford
L. Ashley Cowart

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1154447

3,251 views
4 citations

Review

Published on 02 May 2023

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation

in Lipids in Cardiovascular Disease

Hongzhen Chen
Xiaomin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1138787

8,739 views
14 citations

Original Research

Published on 27 Apr 2023

Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL

in Lipids in Cardiovascular Disease

Sneha S. Pillai
Duane G. Pereira
Jue Zhang
Wenxin Huang
Mirza Ahmar Beg
Darcy A. Knaack
Bruno de Souza Goncalves
Daisy Sahoo
Roy L. Silverstein
Joseph I. Shapiro

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1046495

3,399 views
8 citations

Navigation group

Articles

Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis

The therapeutic potential of sphingolipids for cardiovascular diseases

Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets

Corrigendum: The rationale for the treatment of long-COVID esymptoms—a cardiologist's view

The effect of non-optimal lipids on the progression of coronary artery calcification in statin-naïve young adults: results from KOICA registry

Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis

Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events

Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report

Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients

Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages

U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study

Corrigendum: Loss of hepatic Surf4 depletes lipid droplets in the adrenal cortex but does not impair adrenal hormone production

Circulating sphingolipids in heart failure

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation

Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL